Can You Take Digoxin and Verapamil Together? What You Need to Know About This Documented Interaction

Digoxin and verapamil can be taken together, but this combination requires careful medical monitoring and typically involves a reduction in digoxin dose. When verapamil is added to digoxin therapy, the amount of digoxin in your bloodstream can increase by 50 to 75 percent. This is a major interaction documented in FDA drug labeling and requires physician oversight to adjust therapy and prevent digoxin toxicity.

What the Source Says

The documented interaction between digoxin and verapamil is classified as major in severity. According to FDA drug labeling data curated by the National Library of Medicine, verapamil increases digoxin serum concentration by 50 to 75 percent. This elevation typically requires a digoxin dose reduction of 30 to 50 percent to maintain therapeutic benefit while reducing the risk of toxicity.

The source record identifies the mechanism as P-glycoprotein inhibition. This means verapamil interferes with a specific transport protein in your body that normally helps remove digoxin. As a result, digoxin accumulates to higher levels than expected from the dose alone.

This interaction is well-documented in FDA labeling and represents a standard precaution in clinical practice. It is not a reason to avoid the combination, but rather a reason to ensure that both drugs are prescribed and monitored together by a physician who is aware of the interaction.

How to Understand This

What Digoxin and Verapamil Do

Digoxin is a cardiac glycoside, a medication derived from the foxglove plant, used to treat heart failure and certain heart rhythm disorders. It works by increasing the strength of heart contractions and slowing the heart rate in specific conditions. Digoxin has a narrow therapeutic window, meaning the difference between an effective dose and a toxic dose is relatively small.

Verapamil is a calcium channel blocker, a class of medication that relaxes blood vessels and slows heart rate. It is used to treat high blood pressure, angina (chest pain), and certain arrhythmias (abnormal heart rhythms). Verapamil is often prescribed for patients who also need digoxin—for example, those with heart failure complicated by atrial fibrillation.

Why the Interaction Occurs: P-Glycoprotein Inhibition

The source record specifies that the mechanism is P-glycoprotein inhibition. P-glycoprotein is a transport protein found in the intestines, liver, and kidneys. One of its natural roles is to help move drugs—including digoxin—out of cells and out of the body. This process is called active efflux.

When verapamil is present, it inhibits P-glycoprotein. This means the protein cannot work as efficiently to remove digoxin from your body. The result is that digoxin accumulates in the bloodstream and in tissues more readily than it would if verapamil were not present. This is why serum digoxin concentration increases by 50 to 75 percent.

Why This Matters for Safety

Because digoxin has a narrow therapeutic window, even a modest increase in blood levels can push the drug into the toxic range. Digoxin toxicity can cause nausea, vomiting, visual disturbances, heart rhythm irregularities (including dangerous arrhythmias), and other serious effects. By reducing the digoxin dose by 30 to 50 percent when verapamil is added, physicians aim to keep digoxin levels in the therapeutic range—high enough to be effective but low enough to be safe.

Distinguishing Documented Fact From General Background

The 50 to 75 percent increase in digoxin serum concentration and the P-glycoprotein inhibition mechanism are documented in the source record and in FDA labeling. The recommended dose reduction of 30 to 50 percent is also documented. These are the facts that govern clinical practice for this pair.

General background knowledge about how P-glycoprotein works and why transport proteins matter is useful for understanding the interaction, but the specific numbers and clinical recommendations come from the FDA-curated source material, not from general pharmacology alone.

Who Should Pay Particular Attention

Any patient taking both digoxin and verapamil should expect their physician to be aware of this interaction and to have planned for it. Patients should pay particular attention to dosing instructions if verapamil is being added to an existing digoxin regimen, or if digoxin is being added to existing verapamil therapy. In either case, dose adjustment is typically necessary.

Patients with reduced kidney or liver function may need closer monitoring, because both digoxin and verapamil are metabolized or eliminated through these organs. However, the fundamental interaction—P-glycoprotein inhibition and a 50 to 75 percent increase in digoxin levels—applies to all patients receiving this combination.

Older adults and patients with lower body weight may also be at higher risk for digoxin toxicity if dosing is not carefully adjusted, because they may require lower absolute doses of digoxin to begin with. Again, this reinforces the importance of medical oversight.

Hypothetical Examples

Scenario 1: Adding Verapamil to Existing Digoxin

Imagine a patient who has been taking digoxin 0.25 mg daily for heart failure and is now prescribed verapamil 120 mg three times daily for high blood pressure. The physician is aware of the documented interaction. Before starting verapamil, or shortly after, the physician checks the patient's digoxin level and reviews the dose. Because verapamil will increase digoxin levels by 50 to 75 percent, the physician may reduce the digoxin dose by 30 to 50 percent—for example, to 0.125 mg daily or even less—to keep the total amount of digoxin in the bloodstream at a safe, therapeutic level. The patient would receive updated instructions and may have follow-up blood tests to confirm that levels are in range.

Scenario 2: Adding Digoxin to Existing Verapamil

Now imagine a patient who has been taking verapamil 240 mg daily for atrial fibrillation and is newly prescribed digoxin for additional heart rate and contractility support. The prescribing physician accounts for the interaction by prescribing a lower starting dose of digoxin than might be used in a patient not taking verapamil. The patient receives clear instructions that verapamil is already in their system and will affect how much digoxin accumulates. Follow-up monitoring of heart rate, symptoms, and digoxin levels helps ensure that the combination is working safely.

What to Discuss With a Pharmacist or Physician

If you are taking both digoxin and verapamil, or if one is being added to your current regimen, here are questions and topics worth raising:

• Dose confirmation: Ask your physician or pharmacist to confirm that your digoxin dose has been adjusted for the presence of verapamil, or vice versa. The documented need for a 30 to 50 percent dose reduction is a standard part of this conversation.
• Baseline and monitoring: Ask whether a digoxin blood level (serum concentration) was checked before the combination was started, and whether follow-up testing is planned. Monitoring is the standard of care for this interaction.
• Symptoms of toxicity: Ask your pharmacist or physician to review signs of digoxin toxicity—such as nausea, vomiting, irregular heartbeat, visual changes, or unusual fatigue—so you know what to report if symptoms develop.
• Other medications: Inform your physician or pharmacist of any other drugs you are taking, including over-the-counter medications and supplements. Other P-glycoprotein inhibitors or medications that affect kidney or liver function may compound this interaction.
• Adherence and timing: Confirm the exact dose, frequency, and timing of both medications. Taking doses at different times (if applicable) does not eliminate the interaction, but consistent adherence to the prescribed regimen is important for maintaining stable blood levels.
• Changes in kidney or liver function: If you have any change in kidney or liver function, or if you develop a new condition that affects these organs, inform your physician. This may require further dose adjustment.
• Review of benefits: Ask whether the benefits of taking both drugs together—for example, controlling both heart rate and contractility in atrial fibrillation—outweigh the complexity of the interaction. In many cases, the combination is appropriate and well-managed, but it should be an intentional clinical decision.

Do not start, stop, or change the dose of either medication without explicit instruction from your physician. If you have concerns about your current regimen, schedule a medication review with your pharmacist or physician rather than making changes on your own.

Key Takeaways

• Verapamil increases digoxin blood levels by 50 to 75 percent through P-glycoprotein inhibition, a major interaction documented in FDA drug labeling.
• This interaction typically requires a digoxin dose reduction of 30 to 50 percent when the two drugs are used together, to prevent digoxin toxicity.
• Digoxin has a narrow therapeutic window, meaning the difference between a safe dose and a toxic dose is small; monitoring ensures the combination remains safe.
• Patients taking both drugs should expect their physician to be aware of this interaction and to have planned dose adjustments accordingly.
• Regular communication with a pharmacist or physician about symptoms, dose changes, and follow-up testing is essential for safe use of this combination.

Sources

• DailyMed: FDA Drug Labeling – The National Library of Medicine's repository of current FDA-approved drug labeling, the source for this interaction data.
• RxNorm: Normalized Naming System for Clinical Drugs – NLM's standardized nomenclature for digoxin, verapamil, and other medications, used to identify and link drug interactions.
• OpenFDA – The FDA's public interface for drug and device data, including adverse events and labeling information.
• PubMed – The National Center for Biotechnology Information's database of biomedical literature, where additional peer-reviewed studies on digoxin-verapamil interactions can be found.

Next Steps

If you are currently taking digoxin, verapamil, or both, take time to review your complete medication list. Visit checkdruginteractions.com to check all of your medications for documented interactions. Then discuss the results and any questions with your pharmacist or physician. Medical oversight of this combination is not optional—it is a standard and appropriate part of safe cardiac care.